A carregar...

Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics

BACKGROUND: Healthcare decisions made on the basis of insufficient evidence may potentially have ineffective or even harmful consequences. The proportion of older ages (over 65 years) in randomized controlled trials (RCTs) for severe asthma is not enough to establish whether anti-IL-5/IL-5R therapie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World Allergy Organ J
Main Authors: Principe, Stefania, Benfante, Alida, Calzetta, Luigino, Rogliani, Paola, Scichilone, Nicola
Formato: Artigo
Idioma:Inglês
Publicado em: World Allergy Organization 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6931205/
https://ncbi.nlm.nih.gov/pubmed/31890084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2019.100081
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!